Poland: A Sleeping Giant
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
Address:
Tel:
Web: http://www.torrex-chiesi.com/
Torrex Chiesi Pharma GmbH is a wholly owned subsidiary of Chiesi Farmaceutici S.p.A. and is responsible, within the Chiesi Group, for all activities in the Central and Eastern Europe region, including the Commonwealth of Independent States.
We market and sell specialty pharmaceuticals and medical devices, with a distinct focus on prescription drugs for the hospital sector and resident doctors. A significant proportion of our turnover is generated by exports to the CEE region.
Our product range consists of developments by our parent company, our own products and products licensed from well known partners, with focal point on defined therapeutic areas such as pulmonology, anesthesia, intensive care and rheumatology.
Our activities include production (GMP), clinical testing (GCP) and the development of in-house products. State-of-the-art systems in the areas of quality assurance, process validation, pharmacovigilance, etc ensure the quality and safety of our products.
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
Voivodeships, Polish expenditure on health care system per one resident is still below the European average. In regards to the issue concerning the „expenditure on health care system”, I would…
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but not in healthcare. Do you now…
IMS ‘lives and breathes the pharma industry’ and it is stimulating to come from other forms of consultancy to IMS. You have worked in various businesses. What motivated you to…
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate…
Adamed was founded in 1986 by your father, Mr. Marian Adamkiewicz. The company is today still fully-owned by your family, which is remarkable in such an industry, where family-run businesses…
You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing…
You have been appointed at the head of Pfizer Poland last December. 2010 is a hot year for the group – even very hot for some of the top management…
Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main opportunity of the Polish market lies…
What is PharmaExpert’s role in the Polish pharmaceutical industry? The information that PharmaExpert gathers enables us to give good insight about the evolution of the pharmacists market, the evolution of…
See our Cookie Privacy Policy Here
